155 related articles for article (PubMed ID: 24602611)
1. Seahorse-derived peptide suppresses invasive migration of HT1080 fibrosarcoma cells by competing with intracellular α-enolase for plasminogen binding and inhibiting uPA-mediated activation of plasminogen.
Kim YT; Kim SK; Jeon YJ; Park SJ
BMB Rep; 2014 Dec; 47(12):691-6. PubMed ID: 24602611
[TBL] [Abstract][Full Text] [Related]
2. Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.
Hsiao KC; Shih NY; Fang HL; Huang TS; Kuo CC; Chu PY; Hung YM; Chou SW; Yang YY; Chang GC; Liu KJ
PLoS One; 2013; 8(7):e69354. PubMed ID: 23894455
[TBL] [Abstract][Full Text] [Related]
3. Alpha-enolase plasminogen receptor in myogenesis.
Lopez-Alemany R; Suelves M; Diaz-Ramos A; Vidal B; Munoz-Canoves P
Front Biosci; 2005 Jan; 10():30-6. PubMed ID: 15574344
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae.
Bergmann S; Wild D; Diekmann O; Frank R; Bracht D; Chhatwal GS; Hammerschmidt S
Mol Microbiol; 2003 Jul; 49(2):411-23. PubMed ID: 12828639
[TBL] [Abstract][Full Text] [Related]
5. Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism.
Donet M; Brassart-Pasco S; Salesse S; Maquart FX; Brassart B
Br J Cancer; 2014 Jul; 111(1):139-48. PubMed ID: 24874477
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
7. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.
Miles LA; Dahlberg CM; Plescia J; Felez J; Kato K; Plow EF
Biochemistry; 1991 Feb; 30(6):1682-91. PubMed ID: 1847072
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
Ellis V
J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
[TBL] [Abstract][Full Text] [Related]
11. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
Reinartz J; Link J; Todd RF; Kramer MD
Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.
Obermajer N; Doljak B; Kos J
Mol Cancer; 2009 Oct; 8():88. PubMed ID: 19845941
[TBL] [Abstract][Full Text] [Related]
13. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration.
Bergmann S; Rohde M; Preissner KT; Hammerschmidt S
Thromb Haemost; 2005 Aug; 94(2):304-11. PubMed ID: 16113819
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of the urokinase-type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells.
Kondoh N; Yamada T; Kihara-Negishi F; Yamamoto M; Oikawa T
Br J Cancer; 1998 Sep; 78(6):718-23. PubMed ID: 9743289
[TBL] [Abstract][Full Text] [Related]
15. Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival.
Fulde M; Rohde M; Polok A; Preissner KT; Chhatwal GS; Bergmann S
mBio; 2013 Mar; 4(2):e00629-12. PubMed ID: 23481605
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
19. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
[TBL] [Abstract][Full Text] [Related]
20. Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation.
Brunner G; Reimbold K; Meissauer A; Schirrmacher V; Erkell LJ
Exp Cell Res; 1998 Mar; 239(2):301-10. PubMed ID: 9521847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
